05/19/2025
6:34 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:26 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:59 AM | Novavax (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2025
8:25 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
5:01 AM | Novavax (Filer)
| Form DEFA14A | |
04/29/2025
7:51 AM | Novavax (Filer)
| Form DEF 14A | |
04/29/2025
7:54 AM | Novavax (Filer)
| Form ARS | |
04/29/2025
7:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
7:06 AM | Newton Charles W. (Reporting)
Novavax (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/29/2025
7:08 AM | Newton Charles W. (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2025
7:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for NVAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. |
04/14/2025
3:19 PM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2025
1:52 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2025
7:03 PM | Novavax (Issuer)
Shiver John W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2025
7:04 PM | Novavax (Issuer)
Shiver John W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:33 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:34 PM | Novavax (Issuer)
Trizzino John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:30 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
4:03 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
4:04 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
4:07 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:39 PM | Novavax (Issuer)
O'Hara Elaine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:42 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:43 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:46 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:01 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
7:05 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:41 AM | Novavax (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2025
6:04 PM | MCGLYNN MARGARET G (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:06 PM | Alton Gregg H (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Novavax (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
5:19 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:50 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
4:41 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:52 PM | Novavax (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:44 PM | Novavax (Issuer)
YOUNG JAMES F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:47 PM | King Rachel K. (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:02 PM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144/A | |
12/30/2024
4:27 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
9:31 AM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
4:24 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the May 1st funding window clos |
12/13/2024
4:24 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
11:13 AM | King Rachel K. (Reporting)
Novavax (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2024
5:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:05 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
3:08 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
10:21 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:01 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:19 PM | Novavax (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/16/2024
7:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:08 PM | Dubovsky Filip (Reporting)
Novavax (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:47 PM | Novavax (Issuer)
Trizzino John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
4:06 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:04 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:37 AM | Novavax (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
5:16 AM | Novavax (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
06/20/2024
4:08 PM | Dubovsky Filip (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:35 PM | Novavax (Subject)
SK Bioscience Co., Ltd. (Filed by)
| Form SC 13G/A | |
06/06/2024
6:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
8:35 PM | Novavax (Filer)
| Form DEFA14A | |
05/20/2024
1:42 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form DFAN14A | |
05/20/2024
5:09 AM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form SC 13D/A | |
